Full Text
The Full Text of this article is available as a PDF (927.4 KB).
References
- 1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE III, Weaver WD: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary. Circulation 1996; 94: 2341–2350 [DOI] [PubMed] [Google Scholar]
- 2. de Boer MJ, Hoorntje JCA, Ottervanger JP, Reiffers S, Suryapranata H, Ziljlstra F: Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: Left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994; 23: 1004–1008 [DOI] [PubMed] [Google Scholar]
- 3. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ for the Mayo Coronary Care Unit and Catheterization Laboratory Group : Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685–691 [DOI] [PubMed] [Google Scholar]
- 4. Grines CL, Browne KF, Marco J, Pothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz‐Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group : A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673–679 [DOI] [PubMed] [Google Scholar]
- 5. Michels KB, Yusuf S: Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta‐analysis) of the randomized trials. Circulation 1995; 91: 476–485 [DOI] [PubMed] [Google Scholar]
- 6. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J Jr, Ramos R, Laufer N, Gordon S, Schork MA: A prospective randomized trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 314; 1986: 812–818 [DOI] [PubMed] [Google Scholar]
- 7. Ribeiro EE, Silva LA, Carneiro R, D'Oliviera LG, Gasquez A, Amino JG, Tavares JR, Petrizzio A, Torossian S, Duprat R, Buffolo E, Ellis SG: Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376–380 [DOI] [PubMed] [Google Scholar]
- 8. The Gobal Use Of Strategies To Open Occluded Arteries In Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators : A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621–1628 [DOI] [PubMed] [Google Scholar]
- 9. Zahn R, Koch A, Rustige J, Schiele R, Wirtzfeld A, Neuhaus K, Kuhn H, Gülker H, Senges J, for the ALKK Study Group : Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction: A matched pairs study. Am J Cardiol 79; 1997: 264–269 [DOI] [PubMed] [Google Scholar]
- 10. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H: A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680–684 [DOI] [PubMed] [Google Scholar]
- 11. Hochman, JS , Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley D, McKimlay S, Sanborn T, LeJemtel T, and the SHOCK Registry Investigators : Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 1995; 91: 873–881 [DOI] [PubMed] [Google Scholar]
- 12. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S: Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992; 19: 907–914 [DOI] [PubMed] [Google Scholar]
- 13. O'Keefe JO, Bailey WL, Rutherford BD, Hartzler GO: Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Am J Cardiol 1993; 72: 107G–115G [DOI] [PubMed] [Google Scholar]
- 14. O'Neill W, Brodie BR, Ivanhoe R, Knopf W, Taylor G, O'Keefe JO, Grines CL, Weintraub R, Sickinger BG, Berdan LG, Tcheng JE, Woodlief LH, Strzelecki M, Hartzler G, Califf RM: Primary coronary angioplasty for acute myocardial infarction (the primary angioplasty registry). Am J Cardiol 1994; 73: 627–634 [DOI] [PubMed] [Google Scholar]
- 15. Brodie BR, Grines CL, Ivanhoe R, Knopf W, Taylor G, O'Keefe J, Weintraub RA, Berdan LG, Tcheng JE, Woodlief LH, O'Neill WW, Califf RM: Six‐month clinical and angiographic follow‐up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry. Circulatio 1994; 90: 156–162 [DOI] [PubMed] [Google Scholar]
- 16. Vaitkus PT: Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction: A meta‐analysis. Clin Cardiol 1995; 18: 35–38 [DOI] [PubMed] [Google Scholar]
- 17. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD: A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253–1260 [DOI] [PubMed] [Google Scholar]
- 18. Grassman ED, Johnson SA, Krone RJ: Predictors of success and major complications for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. An analysis of the 1990 to 1994 society for cardiac angiography and interventions registries. J Am Coll Cardiol 1997; 30: 201–208 [DOI] [PubMed] [Google Scholar]
- 19. Zahn R, Vogt A, Seidl K, Schuster S, Gülker H, Heinrich KW, Gottwik M, Neuhaus K, Senges J, for the ALKK Study Group : Balloon angioplasty for acute myocardial infarction: Results from the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) in 4625 patients. Z Kardiol 1997; 86: 712–721 [DOI] [PubMed] [Google Scholar]
- 20. Antiplatelet Trialist' Collaboration : Collaborative overview of randomized trails of antiplatelet therapy‐I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106 [PMC free article] [PubMed] [Google Scholar]
- 21. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico : GISSI‐3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115–1122 [PubMed] [Google Scholar]
- 22. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C: The Goteborg metoprolol trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983; 67: 126–132 [PubMed] [Google Scholar]
- 23. ISIS‐1 (First International Study of Infarct Survival) Collaborative Group : Randomized trial of intravenous atenolol among 16,027 cases of acute myocardial infarction: ISIS‐1. Lancet 1986; 2: 57–66 [PubMed] [Google Scholar]
- 24. ISIS‐4 Collaborative Group. ISIS‐4 : A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685 [PubMed] [Google Scholar]
- 25. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G, for the meeting participants : ACE inhibitors use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 1995; 92: 3132–3137 [DOI] [PubMed] [Google Scholar]
- 26. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wert‐heimer JH, Hawkins CM, for the SAVE investigators : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial (SAVE). N Engl J Med 1992; 327: 669–677 [DOI] [PubMed] [Google Scholar]
- 27. Ryden L, Ariniego R, Amman K, Herlitz J, Hjalmarson A, Holmberg S, Reyes C, Smedgard R, Svedberg K, Vedin A, Waagstein F, Waldenstrom A, Wilhelmsson C, Wedel H, Yamamoto M: A double‐blind trial of metoprolol in acute myocardial infarction: Effects on ventricular tachycardia. N Engl J Med 1983; 308: 614–618 [DOI] [PubMed] [Google Scholar]
- 28. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H, for the CONSENSUS II Study Group : Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992; 327: 678–684 [DOI] [PubMed] [Google Scholar]
- 29. Schuster S, Koch A, Burczyk U, Schiele R, Wagner S, Zahn R, Glunz HG, Heinrich F, Stuby K, Berg G, Voigtländer T, Gieseler U, Jakob M, Hauptmann P, Senges J, for the MITRA Study Group : Frühbehandlung des akuten Myokardinfarkts: Umsetzung von Therapierichtlinien in den klinischen Alltag, MITRA Pilotphase. Z Kardiol 1997; 86: 273–283 [DOI] [PubMed] [Google Scholar]
- 30. Rogers WJ, Baim DS, Gore JM, Brown G, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJT, Zaret BL, Robertson TL, Passami ER, Ross R, Knatterud GL, Braunwald E, for the TIMI II‐A Investigators : Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue‐type plasminogen activator. Circulation 1990; 81: 1457–1476 [DOI] [PubMed] [Google Scholar]
- 31. Simoons ML, Arnold AER, Betriu A, deBono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, Michel PL, Raynaud P, Rutsch W, Sanz GA, Schmidt W, Serruys PW, Thery C, Uebis R, Vahanian A, van der Werf F, Willems GW, Wood D, Verstaete M: Thrombolysis with tissue plasminogen activator in acute myocardial infraction: No additional benefit from immediate percutaneous transluminal coronary angioplasty. Lancet 1988; 1: 197–203 [DOI] [PubMed] [Google Scholar]
- 32. Jollis JG, DeLong ER, Peterson ED, Muhlbaier LH, Fortin DF, Califf RM, Mark DB: Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996; 335: 1880–1887 [DOI] [PubMed] [Google Scholar]